Under the World Trade Organisation's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), countries with major public health problems can issue "compulsory licences" for the manufacture of patent-protected drugs.
Sagaidāms, ka šajā plenārsesijā Parlaments regulas projektu pieņems jau ar Padomi saskaņotajā redakcijā.